Plaintiffs contend companies are illegally raising insulin prices to provide rebates for pharmacy-benefit managers who decide which drugs get on preferred insurance lists.

News of tools, solutions, products from Global Atlantic, , TCG Advisors, Yorktel, Buoy Health, Minnesota Health Action Group, and more.

A portfolio strategist at BlackRock outlined how lower returns over the next 10 years will require a disciplined process.

The ERISA Industry Committee's new SVP for retirement policy, Aliya Robinson, lays out agenda.